Tag: highly variable drugs
Asher Clyne
Replicate Study Designs: Advanced Methods for Bioequivalence Assessment
Replicate study designs are now essential for assessing bioequivalence of highly variable drugs. They reduce sample sizes by up to 75%, enable regulatory-compliant scaling, and are required for drugs like warfarin and levothyroxine. Learn how to choose the right design and avoid common pitfalls.
Continue Reading